Assessing the Relevance of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Qualitative Study
- 1 April 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 18 (4) , e011245
Abstract
BACKGROUND: Validly measuring disease-specific health status is critical in patients with severe tricuspid regurgitation (TR) to quantify the benefit of different interventions. The Kansas City Cardiomyopathy Questionnaire (KCCQ) has been used to assess health status in patients with severe TR, but its content validity in this patient population is unknown, including whether additional questions are needed to supplement the KCCQ. METHODS: Twenty participants with symptomatic severe TR from 2 midwestern clinical sites were interviewed in 2023 using a semistructured guide. The interview guide addressed symptoms, physical and social functioning, and quality of life concepts of the KCCQ, as well as other potential TR symptoms not represented in the KCCQ. Interview transcripts were analyzed using inductive and deductive coding and content analysis, with additional participants recruited until thematic saturation occurred. RESULTS: Mean age of the participants was 80 (41–89), and 75% were female. Shortness of breath and fatigue were reported by virtually all participants (n=20 and n=19, respectively) and had a marked negative impact on their physical and social functioning and quality of life. Lower limb edema was also reported by 10 participants. Although these concepts are captured by the KCCQ, other symptoms were also reported, including appetite loss (n=8) and upper body edema (n=4), but did not seem to markedly affect participants’ function or quality of life. In addition, all participants who experienced these other symptoms reported symptoms that were already captured by the KCCQ. CONCLUSIONS: All participants experienced symptoms captured by the KCCQ, and these symptoms had a substantial impact on their physical and social functioning and quality of life. Although some participants reported additional symptoms not assessed by the KCCQ, their incorporation would only marginally improve content validity. Thus, the current KCCQ appears to be appropriate for capturing the disease-specific health status of patients with severe TR.Keywords
This publication has 30 references indexed in Scilit:
- Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid RegurgitationJAMA Cardiology, 2025
- Health Status After Transcatheter Tricuspid-Valve Repair in Patients With Severe Tricuspid RegurgitationJACC, 2023
- Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic CardiomyopathyJACC: Heart Failure, 2022
- 12‐Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitationCatheterization and Cardiovascular Interventions, 2021
- Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid RegurgitationJACC, 2021
- Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid RegurgitationJACC, 2021
- 1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid RegurgitationJACC: Cardiovascular Interventions, 2019
- Clinical Outcome of Isolated Tricuspid Regurgitation in Patients with Preserved Left Ventricular Ejection Fraction and Pulmonary HypertensionJournal of the American Society of Echocardiography, 2018
- Reliability and Validity of the Kansas City Cardiomyopathy Questionnaire in Patients with Previous Myocardial InfarctionEuropean Journal of Heart Failure, 2005
- Impact of tricuspid regurgitation on long-term survivalJACC, 2004